BUZZ-Medline dips a day after strong Nasdaq debut
I'm PortAI, I can summarize articles.
Medline's shares fell 3.7% to $39.50 premarket, a day after a strong Nasdaq debut where the stock surged 41%. The company opened at $35, above its $29 IPO price, achieving a $46 billion valuation, marking the largest U.S. IPO since Rivian in 2021. Medline sold 216 million shares, exceeding its initial plan of 179 million, at the upper end of the $26-$30 range, raising about $6.3 billion. The proceeds will be used to repay debt and redeem equity interests from pre-IPO owners.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments